APOE3-Christchurch Variant Effects on iPSC-Derived Mesenchymal Stromal Cell Functions

A 1.8 MB PDF from figshare details experimental findings on a protective genetic variant in Alzheimer's Disease research. The work by Paula J. Rodriguez Martinez, last updated in June 2026, compares isogenic iPSC-derived mesenchymal stromal cells (iMSCs) with the APOE3-Christchurch variant against standard APOE3 iMSCs. It reports on their immunosuppressive effects, endothelial barrier support, angiogenic capacity, and promotion of neurite outgrowth.

Use Cases

• Compare immunosuppressive effects on LPS-induced NFκB activation based on the described THP1 cell assay
• Analyze endothelial barrier resistance and angiogenic capacity based on the described co-culture experiments with endothelial cells
• Evaluate neurite outgrowth promotion based on the described conditioned medium experiments
• Investigate metabolic resilience differences between cell lines based on the mentioned metabolic profiling

Strengths

• Data is derived from isogenic iPSC lines, which likely controls for genetic background variability.
• The description details specific, measurable functional assays (immunosuppression, barrier resistance, neurite outgrowth).
• Dataset is openly licensed under CC-BY-4.0, permitting reuse with attribution.

Limitations

• The primary data format is a 1.8 MB PDF, which may contain summarized results rather than raw experimental data.
• Column-level documentation and sample data are unavailable, making direct computational analysis impossible without further information.
• Row count is unknown, which may limit suitability assessment for statistical modeling.

Provenance

Source

Paula J. Rodriguez Martinez via figshare

Collection Method

Experimental data from laboratory studies using isogenic iPSC-derived mesenchymal stromal cells.

Freshness

Last updated 2026-06-01 04:21:03